Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021-2025)
{{output}}
Introduction: PKMYT1, a member of the WEE family of kinases that regulates mitotic entry by phosphorylating CDK1 at Thr14, has recently gained prominence as a promising synthetic lethal target for oncology. Since the first-in-cla... ...